Adapti, Inc. is a U.S.-based early-stage services company that has built an AI-driven software platform to analyze product data, social media signals, and audience behavior to identify the most effective influencers for a given product or brand. The company developed the Adapti platform internally beginning in 2021 and has used third-party AI tools such as ChatGPT, OpenAI, and Google AI to create a "data fingerprint" for products and companies. Management says the platform is intended to improve return on marketing spend by matching products with influencers and curated audiences, and it has been tested in live transactions supporting sales of Dermacia products. In addition to the AI platform, the company has sold licensed consumer products direct-to-consumer and has taken on outsourced programming work to generate limited income while deploying its technical staff.
0.68
0.68
| % | |
|---|---|
| AI marketing platform | 0% Software that analyzes product, company, and social data to identify influencers and optimize campaign ROI. |
| Consumer products | 100% Licensed Dermacia skin care and healthcare products sold direct to consumers. |
| Outsourced services | 0% Programming and related outsourced work performed to generate limited service income. |
Adapti's intended customer base includes brands and product owners that want to use influencer marketing and social...
Buy influencer selection and campaign analytics to improve social media promotion efficiency and ROI.
Buy licensed skin care and healthcare products sold directly by the company.
Uses the platform and related services for social media opportunities and audience engagement.
Buy programming or project-based technical work while the platform is still early-stage.
Adapti is headquartered in the United States and the available disclosures do not provide a country-by-country revenue...
The company's core strategy is to turn the internally developed Adapti platform into a commercial tool for influencer...
The platform has not yet generated revenue, so proving commercial demand is essential to turning development spend into a business.
Better data and feedback loops should improve influencer matching and campaign ROI, which is the platform's core value proposition.
Dependence on Dermacia limits scale, so broader client adoption is needed for the platform to matter economically.
Adapti is an early-stage company with limited operating history, so investors have little evidence that the platform...
The company has spent on development but has not yet generated revenue from Adapti, so the platform's commercial success remains uncertain.
Governments in the U.S., EU, and elsewhere are considering or adopting AI rules that could impose compliance burdens or limit certain uses.
The platform processes proprietary, confidential, and personal data and depends on third-party hosting and cloud providers.
Demand for services and content is sensitive to changing tastes and publicity around the company or its partners.
Competitors with greater resources may build better tools, and some platform elements may not be fully protectable.
AMPL · Services-Prepackaged Software
ANGI · Services-Advertising
AVAI · Services-Computer Processing & Data Preparation
MDAI · Surgical & Medical Instruments & Apparatus
ABSI · Services-Commercial Physical & Biological Research
Absci Corp is a biotechnology company built around its Integrated Drug Creation platform, which combines AI-driven design, wet-lab biology, and computational…
STGW · Services-Advertising Agencies
: 11/08/2026